{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:33:43Z","timestamp":1776882823820,"version":"3.51.2"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1013746"],"award-info":[{"award-number":["APP1013746"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Antimicrobial stewardship programmes are important in driving safety and quality of antimicrobial prescribing. The National Antimicrobial Prescribing Survey (NAPS) is a point-prevalence audit of inpatient antimicrobial prescribing in Australian hospitals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To design and adapt the NAPS tool for use in the outpatient parenteral antimicrobial therapy (OPAT) and hospital-in-the-home (HITH) setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An inter-disciplinary working group with expertise in OPAT and HITH services was established to adapt the NAPS template for use in the OPAT setting\u2014called HITH-NAPS. This was initially trialled in 5 HITH services, subsequently adapted following participant feedback, then offered nationally to 50 services in 2017.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 1154 prescriptions for 715 patients audited via the HITH-NAPS. The most common antimicrobials prescribed were cefazolin (22%), flucloxacillin (12%), piperacillin\/tazobactam (10%) and ceftriaxone (10%). The most common infections treated were cellulitis (30%) and respiratory tract infections (14%). Eighty-seven percent of prescriptions were assessed as appropriate, 11% inappropriate and 2% not assessable. Prolonged durations of antimicrobials and unnecessarily broad-spectrum antibiotics were used in 9% of prescriptions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The HITH-NAPS pilot project revealed that auditing of this type is feasible in HITH. It showed that antibiotic use in these HITH services was generally appropriate, but there are some areas for improvement. A national OPAT\/HITH-NAPS can facilitate benchmarking between services, identify potentially inappropriate prescribing and help guide quality improvement.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jacamr\/dlaa058","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T11:08:43Z","timestamp":1593774523000},"source":"Crossref","is-referenced-by-count":10,"title":["Measuring antimicrobial prescribing quality in outpatient parenteral antimicrobial therapy (OPAT) services: development and evaluation of a dedicated national antimicrobial prescribing survey"],"prefix":"10.1093","volume":"2","author":[{"given":"N Deborah","family":"Friedman","sequence":"first","affiliation":[{"name":"National Centre for Antimicrobial Stewardship, Melbourne, VIC, Australia"},{"name":"Barwon Health, Geelong, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-0884","authenticated-orcid":false,"given":"Seok M","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney","family":"James","sequence":"additional","affiliation":[{"name":"National Centre for Antimicrobial Stewardship, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn","family":"Ingram","sequence":"additional","affiliation":[{"name":"National Centre for Antimicrobial Stewardship, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"Eastern Health, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G D","family":"Pollard","sequence":"additional","affiliation":[{"name":"Barwon Health, Geelong, VIC, Australia"},{"name":"Cabrini Health, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Koning","sequence":"additional","affiliation":[{"name":"Eastern Health, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"George","sequence":"additional","affiliation":[{"name":"National Centre for Antimicrobial Stewardship, Melbourne, VIC, Australia"},{"name":"Pharmacy Department, Royal Melbourne Hospital, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Rajkhowa","sequence":"additional","affiliation":[{"name":"National Centre for Antimicrobial Stewardship, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas F","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia"},{"name":"Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty L","family":"Buising","sequence":"additional","affiliation":[{"name":"National Centre for Antimicrobial Stewardship, Melbourne, VIC, Australia"},{"name":"Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"2021052617293330000_dlaa058-B1","year":"2014"},{"key":"2021052617293330000_dlaa058-B2","year":"2016"},{"key":"2021052617293330000_dlaa058-B3"},{"key":"2021052617293330000_dlaa058-B4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2021052617293330000_dlaa058-B5","author":"Duguid"},{"key":"2021052617293330000_dlaa058-B6","year":"2011"},{"key":"2021052617293330000_dlaa058-B7","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/jac\/dkv047","article-title":"Measuring antimicrobial prescribing quality in Australian hospitals: development and evaluation of a national antimicrobial prescribing survey tool","volume":"70","author":"James","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2021052617293330000_dlaa058-B8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1071\/AH16238","article-title":"Antimicrobial Use and Resistance in Australia (AURA) surveillance system: coordinating national data on antimicrobial use and resistance for Australia","volume":"42","author":"Turnidge","year":"2017","journal-title":"Aust Health Rev"},{"key":"2021052617293330000_dlaa058-B9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1542\/peds.54.3.358","article-title":"Outpatient intravenous medications in the management of cystic fibrosis","volume":"54","author":"Rucker","year":"1974","journal-title":"Pediatrics"},{"key":"2021052617293330000_dlaa058-B10"},{"key":"2021052617293330000_dlaa058-B11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.5694\/j.1326-5377.2002.tb04450.x","article-title":"Hospital-in-the-home treatment of infectious diseases","volume":"176","author":"Howden","year":"2002","journal-title":"Med J Aust"},{"key":"2021052617293330000_dlaa058-B12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5694\/mja12.10480","article-title":"A meta-analysis of \u201chospital in the home\u201d","volume":"197","author":"Caplan","year":"2012","journal-title":"Med J Aust"},{"key":"2021052617293330000_dlaa058-B13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199102073240605","article-title":"The nature of adverse events in hospitalised patients: results of the Harvard Medical Practice Study II","volume":"324","author":"Leape","year":"1991","journal-title":"N Engl J Med"},{"key":"2021052617293330000_dlaa058-B14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1086\/420939","article-title":"Practice guidelines for outpatient parenteral antimicrobial therapy","volume":"38","author":"Tice","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2021052617293330000_dlaa058-B15","first-page":"495","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) and the general physician","volume":"13","author":"Barr","year":"2013","journal-title":"Clin Med (Lond)"},{"key":"2021052617293330000_dlaa058-B16","doi-asserted-by":"crossref","first-page":"f1585","DOI":"10.1136\/bmj.f1585","article-title":"Outpatient parenteral antimicrobial therapy","volume":"346","author":"Chapman","year":"2013","journal-title":"BMJ"},{"key":"2021052617293330000_dlaa058-B17","first-page":"45A","article-title":"Documenting the value of OPAT: outcome studies and patient registries","volume":"11 Suppl A","author":"Tice","year":"2000","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2021052617293330000_dlaa058-B18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000048563","article-title":"The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the outpatient parenteral antimicrobial therapy outcomes registry","volume":"47","author":"Tice","year":"2001","journal-title":"Chemother"},{"key":"2021052617293330000_dlaa058-B19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/jac\/dks003","article-title":"Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement","volume":"67","author":"Chapman","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2021052617293330000_dlaa058-B20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dku517","article-title":"Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists","volume":"70","author":"Gilchrist","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2021052617293330000_dlaa058-B21","year":"2014"},{"key":"2021052617293330000_dlaa058-B22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jama.2016.8825","article-title":"Cellulitis: a review","volume":"316","author":"Raff","year":"2016","journal-title":"JAMA"},{"key":"2021052617293330000_dlaa058-B23","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/jac\/dkz122","article-title":"From \u2018OPAT\u2019 to \u2018COpAT\u2019: implications of the OVIVA study for ambulatory management of bone and joint infection","volume":"74","author":"Seaton","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2021052617293330000_dlaa058-B24","article-title":"Oral vs intravenous antibiotics for patients with Klebsiella pneumoniae liver abscess: a randomized, controlled noninferiority study","author":"Molton","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021052617293330000_dlaa058-B25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med"},{"key":"2021052617293330000_dlaa058-B26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00000441-200508000-00002","article-title":"Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy","volume":"330","author":"Sharma","year":"2005","journal-title":"Am J Med Sci"},{"key":"2021052617293330000_dlaa058-B27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1345\/aph.1Q240","article-title":"Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical centre","volume":"45","author":"Heintz","year":"2011","journal-title":"Ann Pharmacother"},{"key":"2021052617293330000_dlaa058-B28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jhm.1902","article-title":"Contribution of infectious disease consultation toward the care of inpatients being considered for community-based parenteral anti-infective therapy","volume":"7","author":"Shrestha","year":"2012","journal-title":"J Hosp Med"},{"key":"2021052617293330000_dlaa058-B29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/cid\/ciw773","article-title":"Infectious Diseases Society of America position statement on telehealth and telemedicine as applied to the practice of infectious diseases","volume":"64","author":"Siddiqui","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2021052617293330000_dlaa058-B30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.idh.2016.01.002","article-title":"Evaluating antimicrobial therapy: how reliable are remote assessors?","volume":"21","author":"Cotta","year":"2016","journal-title":"Infect Dis Health"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jacamr\/article-pdf\/2\/3\/dlaa058\/38269348\/dlaa058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jacamr\/article-pdf\/2\/3\/dlaa058\/38269348\/dlaa058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T23:44:16Z","timestamp":1667259856000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlaa058\/5881852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlaa058","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,8,6]]},"article-number":"dlaa058"}}